ロード中...
From Laboratory Studies to Clinical Trials: Temozolomide Use in IDH-Mutant Gliomas
In this review, we discuss the use of the alkylating agent temozolomide (TMZ) in the treatment of IDH-mutant gliomas. We describe the challenges associated with TMZ in clinical (drug resistance and tumor recurrence) and preclinical settings (variabilities associated with in vitro models) in treating...
保存先:
| 出版年: | Cells |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8157002/ https://ncbi.nlm.nih.gov/pubmed/34067729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10051225 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|